These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 3954931)

  • 1. Plasma and synovial fluid kinetics of flurbiprofen in rheumatoid arthritis.
    Aarons L; Salisbury R; Alam-Siddiqi M; Taylor L; Grennan DM
    Br J Clin Pharmacol; 1986 Feb; 21(2):155-63. PubMed ID: 3954931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of the enantiomers of flurbiprofen in patients with rheumatoid arthritis.
    Young MA; Aarons L; Toon S
    Br J Clin Pharmacol; 1991 Jan; 31(1):102-4. PubMed ID: 2015160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kinetics of flurbiprofen in synovial fluid.
    Aarons L
    J Pharmacokinet Biopharm; 1991 Jun; 19(3):265-9. PubMed ID: 1875281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of flurbiprofen in serum and synovial fluid from patients with active rheumatoid disease: some preliminary observations.
    Chalmers TM; Glass RC; Risdall PC
    Curr Med Res Opin; 1977; 5(1):17-20. PubMed ID: 303167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of lumiracoxib in plasma and synovial fluid.
    Scott G; Rordorf C; Reynolds C; Kalbag J; Looby M; Milosavljev S; Weaver M; Huff JP; Ruff DA
    Clin Pharmacokinet; 2004; 43(7):467-78. PubMed ID: 15139795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-penicillamine and D-penicillamine-protein disulphide in plasma and synovial fluid of patients with rheumatoid arthritis.
    Joyce DA; Day RO
    Br J Clin Pharmacol; 1990 Oct; 30(4):511-7. PubMed ID: 2291865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transsynovial kinetics of lonazolac and its hydroxy metabolite in synovitis patients.
    Deneke J; Luckow V; Guserle R; Pässler HH
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):418-24. PubMed ID: 9726694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disappearance kinetics of solutes from synovial fluid after intra-articular injection.
    Owen SG; Francis HW; Roberts MS
    Br J Clin Pharmacol; 1994 Oct; 38(4):349-55. PubMed ID: 7833225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein binding of non-steroidal anti-inflammatory drugs in plasma and synovial fluid of arthritic patients.
    Wanwimolruk S; Brooks PM; Birkett DJ
    Br J Clin Pharmacol; 1983 Jan; 15(1):91-4. PubMed ID: 6849750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of flurbiprofen in man. I. Area/dose relationships.
    Szpunar GJ; Albert KS; Bole GG; Dreyfus JN; Lockwood GF; Wagner JG
    Biopharm Drug Dispos; 1987; 8(3):273-83. PubMed ID: 3593904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synovial fluid and plasma kinetics of repeat dose sustained action tiaprofenic acid in patients with rheumatoid arthritis.
    Nichol FE; Samanta A; Rose CM
    Drugs; 1988; 35 Suppl 1():46-51. PubMed ID: 3359945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated plasma and synovial fluid pharmacokinetics of tenoxicam in patients with rheumatoid arthritis and osteoarthritis: factors determining the synovial fluid/plasma distribution ratio.
    Hinderling PH; Hartmann D; Crevoisier C; Moser U; Heizmann P
    Ther Drug Monit; 1988; 10(3):250-60. PubMed ID: 3262939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ibuprofen kinetics in plasma and synovial fluid of arthritic patients.
    Gallo JM; Gall EP; Gillespie WR; Albert KS; Perrier D
    J Clin Pharmacol; 1986 Jan; 26(1):65-70. PubMed ID: 3950052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of salicylate binding to synovial fluid and plasma protein in patients with rheumatoid arthritis.
    Trnavská Z; Trnavský K
    Eur J Clin Pharmacol; 1980 Nov; 18(5):403-6. PubMed ID: 7439262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium naproxen: concentration and effect on inflammatory response mediators in human rheumatoid synovial fluid.
    Bertin P; Lapicque F; Payan E; Rigaud M; Bailleul F; Jaeger S; Treves R; Netter P
    Eur J Clin Pharmacol; 1994; 46(1):3-7. PubMed ID: 8005184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentration of azapropazone in synovial tissues and fluid.
    Spahn H; Thabe K; Mutschler E; Tillmann K; Gikalov I
    Eur J Clin Pharmacol; 1987; 32(3):303-7. PubMed ID: 3595703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein traffic in human synovial effusions.
    Wallis WJ; Simkin PA; Nelp WB
    Arthritis Rheum; 1987 Jan; 30(1):57-63. PubMed ID: 3814198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of hydrogen sulfide in plasma and knee-joint synovial fluid from rheumatoid arthritis patients: relation to clinical and laboratory measures of inflammation.
    Whiteman M; Haigh R; Tarr JM; Gooding KM; Shore AC; Winyard PG
    Ann N Y Acad Sci; 2010 Aug; 1203():146-50. PubMed ID: 20716297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contribution of synovial fluid lipoproteins to the chronic synovitis of rheumatoid arthritis.
    Prete PE; Gurakar-Osborne A
    Prostaglandins; 1997 Oct; 54(4):689-98. PubMed ID: 9440132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change of prostaglandin E level in joint fluids after treatment with flurbiprofen in patients with rheumatoid arthritis and osteoarthritis.
    Tokunaga M; Ohuchi K; Yoshizawa S; Tsurufuji S; Rikimaru A; Wakamatsu E
    Ann Rheum Dis; 1981 Oct; 40(5):462-5. PubMed ID: 7305470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.